Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies – PR Newswire Leave a Comment / Mega Deals / By Lilly to buy Kelonia Therapeutics to advance in vivo CAR-T cell therapies PR Newswire Source: news.google.com
